$370.23
4.961.36%
最終更新: Sep 30, 2:46 PM
Benzinga
Benzinga
Benzinga
水曜日, 9 30
BeOne Medicines Ltd
ONCNASDAQ
BeOne Medicines Earnings & Forecasts
BeOne Medicines (ONC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
BeOne Medicines Guidance
BeOne Medicines (ONC) は、8 5, 2026日にfiscal yearの2026に関するガイダンスを直近で発表しました。同社は当期の売上高を$6.6B - $6.8Bの範囲と予想しています。
以前のガイダンスと比較して、BeOne Medicinesは売上高予測を以前の範囲である引き上げから$6.3B - $6.5Bに引き上げました。
BeOne Medicinesは、7から2 27, 2025の間に8 5, 2026ガイダンスの更新を発表しました。During this period, the company raised its outlook 3 times, reflecting management's growing confidence in business performance.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.44 | $0.79 | $1.42 | $0.80 |
| Actual | $3.84 | $3.24 | $1.95 | $2.65 |
| Surprise | +166.7% | +310.1% | +37.3% | +231.3% |
| Revenue | ||||
| Estimate | $1.59B | $1.44B | $1.45B | $1.35B |
| Actual | $1.71B | $1.51B | $1.50B | $1.41B |
| Surprise | +7.19% | +5.00% | +3.10% | +4.26% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.94 | $1.65 | $2.96 | $3.31 |
| Revenue | ||||
| Consensus | $1.76B | $1.79B | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved